Losartan Potassium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Losartan Potassium Price Trend, Index and Forecast
Track the latest insights on losartan potassium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Losartan Potassium Prices Outlook Q3 2025
- USA: USD 170500/MT
- China: USD 50225/MT
- India: USD 52100/MT
- Brazil: USD 65200/MT
- Argentina: USD 67150/MT
Losartan Potassium Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the losartan potassium prices in the USA reached 170500 USD/MT in September. Prices moved downward as procurement from finished dosage manufacturers moderated and distributors relied on existing inventories. Stable API availability and cautious purchasing behavior influenced sourcing decisions. Buyers focused on meeting near-term formulation requirements rather than expanding inventory positions.
During the third quarter of 2025, the losartan potassium prices in China reached 50225 USD/MT in September. Prices declined due to reduced export demand and sufficient domestic availability. Softer overseas orders and controlled production rates influenced procurement volumes. Buyers emphasized inventory optimization and short-term sourcing aligned with confirmed manufacturing needs.
During the third quarter of 2025, the losartan potassium prices in India reached 52100 USD/MT in September. Prices increased as demand from domestic formulation units and export-oriented pharmaceutical manufacturers strengthened. Higher offtake for regulated markets supported procurement activity. Buyers aligned sourcing with production schedules and compliance requirements.
During the third quarter of 2025, the losartan potassium prices in Brazil reached 65200 USD/MT in September. Prices moved downward amid reduced public healthcare procurement and cautious distributor purchasing. Adequate import availability influenced sourcing behavior. Buyers limited procurement to immediate formulation needs.
During the third quarter of 2025, the losartan potassium prices in Argentina reached 67150 USD/MT in September. Prices declined as demand from pharmaceutical distributors softened. Import availability and inventory management strategies influenced procurement decisions, with buyers prioritizing short-term operational coverage.
Losartan Potassium Prices Outlook Q2 2025
- USA: USD 174693/MT
- China: USD 51832/MT
- India: USD 50780/MT
- Brazil: USD 67495/MT
- Argentina: USD 68731/MT
During the second quarter of 2025, the losartan potassium prices in the USA reached 174693 USD/MT in June. Demand from pharmaceutical formulation and distribution channels shaped procurement activity. Buyers aligned sourcing with confirmed manufacturing requirements and inventory planning.
During the second quarter of 2025, the losartan potassium prices in China reached 51832 USD/MT in June. Consumption from export-oriented API manufacturing influenced procurement patterns. Domestic production capacity and inventory availability supported material access.
During the second quarter of 2025, the losartan potassium prices in India reached 50780 USD/MT in June. Demand from formulation units and regulated market supplies guided sourcing decisions. Buyers coordinated procurement with production schedules and compliance needs.
During the second quarter of 2025, the losartan potassium prices in Brazil reached 67495 USD/MT in June. Procurement was influenced by public healthcare demand and distributor inventory management. Buyers structured sourcing around confirmed supply requirements.
During the second quarter of 2025, the losartan potassium prices in Argentina reached 68731 USD/MT in June. Demand from pharmaceutical distributors shaped procurement volumes. Import availability and logistics considerations influenced sourcing timelines.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the losartan potassium prices.
Europe Losartan Potassium Price Trend
Q3 2025:
As per the losartan potassium price index, losartan potassium market conditions were shaped by procurement behavior across import-dependent pharmaceutical markets. Demand from generic cardiovascular drug manufacturers remained steady, with buyers relying on long-term contracts and existing inventories. Regulatory compliance, batch certification, and documentation requirements influenced sourcing decisions. Import availability supported supply continuity, while procurement activity remained closely aligned with confirmed formulation schedules and distributor demand rather than speculative or forward inventory accumulation.
Q2 2025:
In Europe, losartan potassium demand was shaped by routine pharmaceutical formulation activity and distributor-led sourcing across generic drug portfolios. Buyers coordinated procurement with production planning, regulatory documentation, and quality assurance requirements. Import availability and established logistics networks supported material access. Purchasing strategies emphasized specification compliance, traceability, and uninterrupted supply for ongoing antihypertensive drug manufacturing rather than responding to short-term market fluctuations.
This analysis can be extended to include detailed losartan potassium price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Losartan Potassium Price Trend
Q3 2025:
As per the losartan potassium price index, North America experienced downward price movement, led by declines in the USA. Moderated demand from finished dosage manufacturers and distributor inventory drawdowns influenced regional consumption. Buyers adopted conservative sourcing strategies, focusing on short-term operational coverage and minimizing excess stock. Established distribution networks and import availability supported supply continuity, while procurement decisions remained closely aligned with confirmed prescription demand and formulation schedules.
Q2 2025:
In North America, losartan potassium demand reflected procurement aligned with pharmaceutical formulation schedules and distributor inventory management. Buyers coordinated sourcing with regulatory compliance requirements, batch release timelines, and production planning. Import flows and established supplier relationships supported material availability. Procurement strategies focused on maintaining uninterrupted access for regulated manufacturing operations and ensuring consistency in quality and documentation.
Specific losartan potassium historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Losartan Potassium Price Trend
Q3 2025:
As per losartan potassium price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the losartan potassium pricing trends and losartan potassium price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on losartan potassium prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Losartan Potassium Price Trend
Q3 2025:
Asia Pacific exhibited mixed price movement, with upward momentum in India and downward pressure in China. Strong demand from Indian formulation units supplying both domestic and export markets supported consumption, while reduced export orders and sufficient availability softened Chinese offtake. Buyers adjusted sourcing strategies based on country-specific demand visibility and regulatory destination requirements. Domestic production capacity and regional trade flows supported material access across key manufacturing hubs.
Q2 2025:
In Asia Pacific, losartan potassium demand was shaped by pharmaceutical formulation activity across China and India. Buyers coordinated procurement with production planning, export order schedules, and compliance documentation requirements. Domestic supply availability and regional trade supported continuity, while procurement strategies emphasized operational alignment, batch traceability, and meeting regulated market specifications.
This losartan potassium price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Losartan Potassium Price Trend
Q3 2025:
Losartan potassium prices in Latin America moved downward, led by declines in Brazil and Argentina. Reduced public healthcare procurement and cautious distributor purchasing softened regional consumption. Buyers limited sourcing volumes amid controlled prescription demand and inventory optimization efforts. Import availability supported supply, allowing procurement to remain closely aligned with confirmed formulation needs and tender-based requirements rather than forward stock building.
Q2 2025:
In Latin America, losartan potassium procurement reflected demand from pharmaceutical distributors and formulation units supplying public and private healthcare channels. Buyers scheduled sourcing based on confirmed healthcare supply commitments and tender cycles. Import flows and logistics planning supported material availability, while procurement strategies focused on ensuring continuity of supply for regulated pharmaceutical use and managing inventory efficiently.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Losartan Potassium Pricing Report, Market Analysis, and News
IMARC's latest publication, “Losartan Potassium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the losartan potassium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of losartan potassium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed losartan potassium prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting losartan potassium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Losartan Potassium Industry Analysis
The global losartan potassium industry size reached 25.9 Thousand Tons in 2025. By 2034, IMARC Group expects the market to reach 37.1 Thousand Tons, at a projected CAGR of 4.06% during 2026-2034. Market growth is driven by rising prevalence of hypertension, increasing demand for generic cardiovascular drugs, expanding pharmaceutical manufacturing capacity, and continued reliance on losartan potassium in regulated and emerging healthcare markets worldwide.
Latest News and Developments:
- March 2025: Scienture Holdings announced that the U.S. Food and Drug Administration (FDA) approved a new oral suspension formulation of losartan potassium, branded Arbli, with a concentration of 10 mg/mL for the treatment of hypertension and reduction of stroke risk in certain patient populations. The approval marks the first ready-to-use oral liquid formulation of losartan potassium in the U.S.
Product Description
Losartan potassium is a medication commonly used to manage hypertension and to help protect the kidneys from damage due to diabetes. It is also prescribed to treat heart failure and lower the risk of strokes in patients with an enlarged heart and high blood pressure. Losartan belongs to a class of drugs known as angiotensin II receptor blockers (ARBs), which work by blocking the action of angiotensin II, a chemical in the body that causes blood vessels to tighten and narrow.
Losartan potassium is also known for its renal protective properties, particularly in patients with type 2 diabetes. It can help to reduce the progression of diabetic nephropathy, which is a type of kidney disease that is a common complication of diabetes. Losartan potassium is taken orally, typically once per day, and is available under various brand names and generic medication.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Losartan Potassium |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Losartan Potassium Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of losartan potassium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting losartan potassium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The losartan potassium price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.